{"id":"W2167923186","doi":"10.1200/jco.2010.30.2729","title":"Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme","year":2010,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":452,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Cohort; Oncology; Radiation therapy; Prospective cohort study; Glioblastoma; Cancer; Phases of clinical research; Toxicity; Surgery; Chemotherapy; Cancer research","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03003219702978245,"score_gpt":0.3977699316817624,"score_spread":0.36773773465198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}